A Universal Plasticizer Alkylsulfonic Phenyl Ester Activates Pregnane X Receptor to Increase Intestinal Cholesterol Uptake
Alkylsulfonic phenyl ester (ASE) is an alternate non-phthalate plasticizer used in PVC and polyurethane manufacture, such as for medical tubing and toys. Plastic-associated endocrine disrupting chemicals have been associated with increased cardiovascular disease risks and have been established as the agonists of a xenobiotic sensor, pregnane X receptor (PXR), which has atherogenic and dyslipidemic effects. However, it is unknown whether ASE activates PXR to adversely affect cardiovascular system. Our objective is to investigate how ASE impacts lipid profiles and cholesterol uptake via PXR signaling. Human hepatic and intestinal cells were used to test activation of PXR by ASE. The computational docking study and site-directed mutagenesis were used to identify key amino acid residues in PXR that interacted with ASE. The natural PXR inhibitor resveratrol was used to prohibit PXR activities. The male C57BL/6 wildtype mice were fed with ASE to evaluate if ASE could alter plasma lipid levels. Our data suggested that ASE was a specific PXR agonist and increased atherogenic cholesterol levels in mice mediated by PXR. Furthermore, ASE treatment increased cholesterol uptake by human intestinal cells through PXR signaling. Our study elucidates the role of PXR as a mediator of xenobiotic-elicited dyslipidemia and provides evidence for the future risk assessment of ASE on cardiovascular diseases.
Authors
- Michael A. Moxley (ORCID: https://orcid.org/0000-0002-6988-1964)
- Yipeng Sui (ORCID: https://orcid.org/0000-0002-6080-0806)
- Naara Ramirez
- Wangeci Kariuki
- Nnamdi Okore
- Conner Brown
Institutions
- University of Nebraska at Kearney (US)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-09-15
- DOI
- https://doi.org/10.3390/ijms27188189
- Primary Topic
- Effects and risks of endocrine disrupting chemicals
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute of General Medical Sciences